NASDAQ:LFCR Lifecore Biomedical (LFCR) Stock Price, News & Analysis $6.54 +0.01 (+0.08%) Closing price 03:59 PM EasternExtended Trading$6.53 -0.01 (-0.14%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Lifecore Biomedical Stock (NASDAQ:LFCR) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Lifecore Biomedical alerts:Sign Up Key Stats Today's Range$6.53▼$6.5550-Day Range$4.09▼$6.5952-Week Range$3.63▼$8.98Volume426,153 shsAverage Volume250,109 shsMarket Capitalization$247.35 millionP/E RatioN/ADividend YieldN/APrice Target$6.50Consensus RatingReduce Company Overview Lifecore Biomedical, Inc. is a contract development and manufacturing organization (CDMO) that provides services to pharmaceutical, biotechnology and medical device companies. The company specializes in complex sterile injectable products and supports customers through product development, process development, manufacturing, aseptic filling, packaging and related regulatory services. Lifecore’s capabilities include the production of injectable products using fermentation and other specialized manufacturing processes. The company is also known for its expertise in hyaluronic acid, which is used in pharmaceutical, ophthalmic and medical device applications. Its services are designed to support products from early development through commercial-scale production. The company operates a manufacturing facility in Chaska, Minnesota, and serves customers in the United States and international markets. Lifecore Biomedical was formerly part of Landec Corporation. Following the divestiture of Landec’s food business, Landec changed its name to Lifecore Biomedical in 2023 to reflect its focus on pharmaceutical and life sciences manufacturing.AI Generated. May Contain Errors. Read More Lifecore Biomedical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks12th Percentile Overall ScoreLFCR MarketRank™: Lifecore Biomedical scored higher than 12% of companies evaluated by MarketBeat, and ranked 850th out of 892 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.9 / 5Analyst RatingReduce Consensus RatingLifecore Biomedical has received a consensus rating of Reduce. The company's average rating score is 1.80, and is based on no strong buy ratings, no buy ratings, 4 hold ratings, and 1 sell rating.Upside/DownsideThe consensus price target for Lifecore Biomedical is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageLifecore Biomedical has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Lifecore Biomedical's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Lifecore Biomedical are expected to decrease in the coming year, from ($1.02) to ($1.08) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Lifecore Biomedical is -6.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Lifecore Biomedical is -6.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioLifecore Biomedical has a P/B Ratio of 15.56. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Lifecore Biomedical's valuation and earnings. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted10.48% of the float of Lifecore Biomedical has been sold short.Short Interest Ratio / Days to CoverLifecore Biomedical has a short interest ratio ("days to cover") of 15.94, which indicates bearish sentiment.Change versus previous monthShort interest in Lifecore Biomedical has recently increased by 10.20%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldLifecore Biomedical does not currently pay a dividend.Dividend GrowthLifecore Biomedical does not have a long track record of dividend growth. News and Social Media1.9 / 5News Sentiment-0.03 News SentimentLifecore Biomedical has a news sentiment score of -0.03. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.49 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 23 news articles for Lifecore Biomedical this week, compared to 3 articles on an average week.MarketBeat Follows1 people have added Lifecore Biomedical to their MarketBeat watchlist in the last 30 days. Company Ownership1.4 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Lifecore Biomedical insiders have not sold or bought any company stock.Percentage Held by Insiders32.68% of the stock of Lifecore Biomedical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions83.36% of the stock of Lifecore Biomedical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Lifecore Biomedical's insider trading history. Receive LFCR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lifecore Biomedical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LFCR Stock News HeadlinesLifecore Biomedical (NASDAQ:LFCR) Stock Rating Lowered by Barrington ResearchOctober 1 at 1:24 AM | americanbankingnews.comHalper Sadeh LLC is Investigating Whether LFCR and SSTI are Obtaining Fair Deals for their ShareholdersSeptember 30 at 9:17 PM | globenewswire.comThe end of AI data centers coming?Marc Chaikin's Power Gauge system flagged Micron before it soared 970 percent, Celestica before a 6,600 percent run, and Nvidia before it climbed more than 50,000 percent. Now Chaikin says a new AI data center technology using 99 percent less electricity, water, and space could accelerate scientific breakthroughs 360-fold, and one company behind it just flashed bullish in his system. See the full research and the ticker Chaikin is watching before this presentation goes offline.October 2 at 1:00 AM | Chaikin Analytics (Ad)Lifecore Biomedical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lifecore Biomedical, Inc. - LFCRSeptember 30 at 7:05 PM | businesswire.comBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Capital Bancorp, Inc. (Nasdaq – CBNK), Lifecore Biomedical, Inc. (Nasdaq – LFCR), MISTRAS Group, Inc. (NYSE – MG), Utz Brands, Inc. (NYSE – UTZ)September 30 at 2:04 PM | globenewswire.comLifecore agrees to acquisition with CVRs up to $160 millionSeptember 30 at 2:03 AM | americanbankingnews.comLifecore Biomedical (NASDAQ:LFCR) Rating Lowered to "Hold" at William BlairSeptember 30 at 1:30 AM | americanbankingnews.com$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Lifecore Biomedical, Inc. (NASDAQ: LFCR)September 29 at 3:00 PM | prnewswire.comSee More Headlines LFCR Stock Analysis - Frequently Asked Questions How have LFCR shares performed this year? Lifecore Biomedical's stock was trading at $8.18 at the beginning of 2026. Since then, LFCR stock has decreased by 20.1% and is now trading at $6.5350. How were Lifecore Biomedical's earnings last quarter? Lifecore Biomedical, Inc. (NASDAQ:LFCR) released its earnings results on Wednesday, August, 5th. The company reported ($0.19) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.19). The firm earned $34.17 million during the quarter, compared to analysts' expectations of $34.18 million. Read the conference call transcript. How do I buy shares of Lifecore Biomedical? Shares of LFCR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Lifecore Biomedical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Lifecore Biomedical investors own include JPMorgan Chase & Co. (JPM), Advanced Micro Devices (AMD), Tesla (TSLA), Meta Platforms (META), NVIDIA (NVDA), Netflix (NFLX) and Visa (V). Company Calendar Last Earnings8/05/2026Today10/02/2026Next Earnings (Estimated)10/02/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2w+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 For the last 2 weeks, LFCR's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:LFCR CIK1005286 Webwww.lifecore.com Phone(952) 368-4300Fax650-368-9818Employees382Year Founded1965Price Target and Rating Average Price Target for Lifecore Biomedical$6.50 High Price Target$6.50 Low Price Target$6.50 Potential Upside/Downside-0.5%Consensus RatingReduce Rating Score (0-4)1.80 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($1.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net Margins-29.93% Pretax MarginN/A Return on EquityN/A Return on Assets-16.16% Debt Debt-to-Equity RatioN/A Current Ratio3.87 Quick Ratio2.69 Sales & Book Value Annual Sales$128.87 million Price / Sales1.92 Cash FlowN/A Price / Cash FlowN/A Book Value$0.42 per share Price / Book15.56Miscellaneous Outstanding Shares37,850,000Free Float25,483,000Market Cap$247.35 million OptionableOptionable Beta0.97 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:LFCR) was last updated on 10/2/2026 by MarketBeat.com Staff. From Our PartnersElon Warns "America Will Go Bankrupt". Trump's Plan Inside.National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...American Hartford Gold | SponsoredA new kind of civil war is coming after election day?Across America, AI-driven backlash is fueling protests, lawsuits, and moratoria that could reshape the politic...Stansberry Research | SponsoredThey're not buying gold. They're buying this.Bank of America raised its stake in a small gold company by 139%. Jane Street increased its position by 159%, ...Behind the Markets | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredMy next big call (under $1)Crypto traders have a name for this month... Uptober. Since 2013, Bitcoin has closed October higher in 10 of 1...Crypto 101 Media | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredHow Elon’s Empire Ends (and how to profit)Marc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg termi...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lifecore Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lifecore Biomedical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
